Non-small Cell Lung Cancer (NSCLC), Recurrent
Also known as: Recurrent Non-Small Cell Lung Cancer (NSCLC) / Recurrent Non-Small Lung Cell Cancer / Lung Cancer, Nonsmall Cell, Recurrent / Recurrent Lung Cancer, Nonsmall Cell / Recurrent Nonsmall Cell Lung Cancer / Non Small Cell Lung Cancer Recurrent / Recurrent Non Small Cell Lung Cancer / Non-Small Cell Lung Cancer Recurrent / Recurrent Non-small Cell Lung Cancer / Lung cancer non-small cell recurrent
Drug | Drug Name | Drug Description |
---|---|---|
DB06186 | Ipilimumab | A human cytotoxic T-lymphocyte antigen 4 (CTLA-4) blocking antibody used to treat metastatic or unresectable melanoma. |
DB09035 | Nivolumab | A PD-1 blocking antibody used to treat melanoma, non small-cell lung cancer, renal cell cancer, head and neck cancer, and Hodgkin lymphoma. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB06186 | Ipilimumab | Cytotoxic T-lymphocyte protein 4 | target |
DB09035 | Nivolumab | Programmed cell death protein 1 | target |
DB09035 | Nivolumab | Programmed cell death 1 ligand 1 | target |